Science

Neeraj Agarwal: Overview of T-cell engagers in prostate cancer

Neeraj Agarwal/primeinc.org

Mar 12, 2025, 11:34

Neeraj Agarwal: Overview of T-cell engagers in prostate cancer

Neeraj Agarwal, Professor of Medicine and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared an article by Chadi Hage Chehade, et al. on X:

“Just in European Urology – Overview of T-cell engagers (TCEs) in prostate cancer. Promising anti-tumor activity, but challenges remain.

Congrats to Chadi Hage Chehade, Zeynep Irem Ozay and the team at GU Cancer Research Program at HuntsmanCancer, Emmanuel Antonarakis, and Arun Azad.“

T-cell Engagers in Prostate Cancer.

Authors: Chadi Hage Chehade, et al.

Neeraj Agarwal: Overview of T-cell engagers in prostate cancer

Arun Azad cancer Cancer research Chadi Hage Chehade Emmanuel Antonarakis european urology fight against cancer Global fight against cancer GU Cancer Research Program HCI Huntsman Cancer Institute Neeraj Agarwal OncoDaily Oncology prostate cancer T-cell engagers TCEs Zeynep Irem Ozay

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Special Coverage